Risks for soft tissue sarcoma

Last medical review:

Some things can affect your risk, or chance, of developing cancer. Certain behaviours, substances or conditions can increase or decrease the risk. Most cancers are the result of many risks. But sometimes cancer develops in people who don’t have any risks.

Soft tissue sarcoma can develop at any age, but it occurs most often in people older than 50 years of age. Exposure to radiation is the main risk for soft tissue sarcoma.

Most of these risks can’t be changed. But in some cases, there are things you can do to lower your risk.

The following can increase your risk for soft tissue sarcoma:

Exposure to radiation

Genetic conditions

Contact with vinyl chloride at work

Contact with thorium dioxide (Thorotrast)

Chronic lymphedema

Certain infections

Weak immune system

Exposure to radiation

Ionizing radiation is a known risk for cancer. The risk depends on how much radiation someone is exposed to.

People who have had radiation therapy as treatment for the following have a higher risk of developing soft tissue sarcoma:

  • Hodgkin lymphoma
  • non-Hodgkin lymphoma
  • a head or neck cancer
  • breast cancer
  • cancer in childhood

This risk is usually outweighed by the benefit of treating the original cancer. If soft tissue sarcoma develops, it usually occurs within 10 years of the radiation exposure.

Genetic conditions

A genetic condition is a disease caused by a change (mutation) in one or more genes. If you have a genetic condition that increases your risk for soft tissue sarcoma, you may need to visit your doctor more often. Talk to your doctor about your risk and if you need to have certain tests to check for soft tissue sarcoma.

Having any of these inherited genetic conditions increases your risk of soft tissue sarcoma.

Retinoblastoma is a rare eye cancer that occurs in children. The genetic version of retinoblastoma is called familial retinoblastoma. People who have familial retinoblastoma as children have a higher risk of developing soft tissue sarcoma.

Neurofibromatosis type 1 is a condition that affects the nervous system. It affects the development and growth of neurons (nerve cells), causes tumours (neurofibromas) to grow on nerves, and may produce other abnormalities in muscles, bones and skin. Sometimes cancerous tumours called malignant peripheral nerve sheath tumours may grow along the nerves.

Neurofibromatosis type 1 increases the risk of soft tissue sarcoma, neuroendocrine tumours, brain tumours, leukemia and neuroblastoma.

Li-Fraumeni syndrome is a condition that is associated with an increased risk of developing certain types of cancers, including soft tissue sarcoma, breast cancer, brain tumours, acute leukemia, bone cancer, and adrenal cortical carcinoma.

People with Li-Fraumeni syndrome tend to develop several different types of cancer before the age of 45.

Werner syndrome is a condition that causes the body to age very rapidly after puberty. Werner syndrome increases the risk for soft tissue sarcoma, melanoma, bone cancer and thyroid cancer.

Contact with vinyl chloride at work

Vinyl chloride is used in the plastics industry to make polyvinyl chloride (PVC), which is used in many products. Coming into contact with vinyl chloride at work increases the risk of developing a type of soft tissue sarcoma called angiosarcoma of the liver.

Following health and safety guidelines can help you lower your contact with vinyl chloride and reduce your risk of soft tissue sarcoma.

Contact with thorium dioxide (Thorotrast)

Thorium dioxide (Thorotrast) is a radioactive contrast medium that was once used for imaging tests. People who were given Thorotrast have a greater risk of developing a type of soft tissue sarcoma called angiosarcoma of the liver. Because it was found to increase the risk for some cancers, Thorotrast is no longer used.

Chronic lymphedema

Lymphedema is swelling that happens when lymph fluid can’t flow normally and builds up in the soft tissues of a limb. Long-term, or chronic, lymphedema can increase the risk for a type of soft tissue sarcoma called angiosarcoma.

Certain infections

Infections with the following viruses increase the risk of developing Kaposi sarcoma, a type of soft tissue sarcoma.

Kaposi sarcoma herpes virus (KSHV) is a type of herpes virus. KSHV is also called Human herpesvirus 8 (HHV-8).

Human immunodeficiency virus (HIV) is the virus that causes AIDS. HIV weakens the body’s immune system.

Weak immune system

Having a weak immune system (immunosuppression) increases your risk for Kaposi sarcoma, a type of soft tissue sarcoma. You may have a weak immune system for different reasons. This includes if you have had an organ transplant and must take medicines to suppress your immune system.

Possible risks

The following have been linked with soft tissue sarcoma, but more research is needed to know for sure that they are risks:

  • previous chemotherapy treatment
  • a personal history of cancer
  • coming into contact with dioxin at work

Understanding your cancer risk

To make the decisions that are right for you, ask your doctor questions about risks. Learn how cancer can be prevented and what you can do to reduce your risk.

Expert review and references

  • Canadian Cancer Society | Société canadienne du cancer
  • Ahrens W, Livingston M, Lopez R, Crimaldi AJ, Kneisl J. Uncommon Tumors of Soft Tissue. Raghavan D, Ahluwalia MS, Blanke CD, et al, eds.. Textbook of Uncommon Cancer . 5th ed. Hoboken, NJ: Wiley Blackwell; 2017.
  • Berwick M, Wiggins C. Soft tissue sarcoma. Thun MJ (ed.). Schottenfeld and Fraumeni Cancer Epidemiology and Prevention. 4th ed. New York, NY: Oxford University Press; 2018: 43:829-838.
  • International Agency for Research on Cancer (IARC). IARC Monographs on the Idenification of Carcinogenic Hazards to Humans Volume 78: Ionizing Radiation Part 2: Some Internally Deposited Radionuclides. 2001.
  • International Agency for Research on Cancer (IARC). IARC Monographs on the Idenification of Carcinogenic Hazards to Humans Volume 75: Ionizing Radiation Part 1: X- and Gamma (y)-Radiation, and Neutrons. 2000.
  • International Agency for Research on Cancer (IARC). Volume 70: Epstein-Barr virus and Kaposi's sarcoma herpesvirus/human herpesvirus 8. 1997.
  • International Agency for Research on Cancer (IARC). Volume 97: 1,3-Butadiene, Ethylene Oxide and Vinyl Halides (Vinyl Fluoride, Vinyl Chloride and Vinyl Bromide). 2008.
  • International Agency for Research on Cancer (IARC). IARC Monographs on the Idenification of Carcinogenic Hazards to Humans Volume 69: Polychlorinated Dibenzo-para-dioxins and Polychlorinated Dibenzofurans. 1997.
  • International Agency for Research on Cancer (IARC). IARC Monographs on the Idenification of Carcinogenic Hazards to Humans Volume 100D: Radiation: A Review of Human Carcinogens. 2011.
  • International Agency for Research on Cancer (IARC). IARC Monographs on the Idenification of Carcinogenic Hazards to Humans Volume 100F: Chemical Agents and Related Occupations: A Review of Human Carcinogens. 2012.
  • International Agency for Research on Cancer (IARC). Volume 100B: Biological agents: A Review of Human Carcinogens. 2012.
  • Ishida Y, Maeda M, Adachi S, et al. Secondary bone/soft tissue sarcoma in childhood cancer survivors: a nationwide hospital-based case-series study in Japan. Japanese Journal of Clinical Oncology. 2018: 48(9):801–814. https://academic.oup.com/jjco/article/48/9/806/5058984.
  • National Toxicology Program. Report on Carcinogens. 15 ed. Research Triangle Park, NC: US Department of Health and Human Services, Public Health Service; 2021. https://ntp.niehs.nih.gov/whatwestudy/assessments/cancer/roc/index.html.
  • PDQ Adult Treatment Editorial Board. Soft Tissue Sarcoma Treatment (PDQ®) – Health Professional Version . Bethesda, MD: National Cancer Institute; https://www.cancer.gov/.
  • Schaffer DH, Poole ND, Downs JW. Vinyl Chloride Toxicity. StatPearls [Internet]. StatPearls Publishing; 2025. https://www.statpearls.com/.
  • Singer S, Tap WD, Kirsch DG, Agaram NP, D'Angelo SP, Crago AM. Soft Tissue Sarcoma. DeVita VT Jr, Lawrence TS, Rosenberg S. eds. DeVita Hellman and Rosenberg's Cancer: Principles and Practice of Oncology . 12th ed. Philadelphia, PA: Wolters Kluwer; 2023: Kindle version, [chapter 60], https://read.amazon.ca/?asin=B0BG3DPT4Q&language=en-CA.

Your trusted source for accurate cancer information

With support from readers like you, we can continue to provide the highest quality cancer information for over 100 types of cancer.

We’re here to ensure easy access to accurate cancer information for you and the millions of people who visit this website every year. But we can’t do it alone.

Every donation helps fund reliable cancer information, compassionate support services and the most promising research. Please give today because every contribution counts. Thank you.

Medical disclaimer

The information that the Canadian Cancer Society provides does not replace your relationship with your doctor. The information is for your general use, so be sure to talk to a qualified healthcare professional before making medical decisions or if you have questions about your health.

We do our best to make sure that the information we provide is accurate and reliable but cannot guarantee that it is error-free or complete.

The Canadian Cancer Society is not responsible for the quality of the information or services provided by other organizations and mentioned on cancer.ca, nor do we endorse any service, product, treatment or therapy.


1-888-939-3333 | cancer.ca | © 2026 Canadian Cancer Society